PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

To improve immunotherapy, researchers look to shift immune cells' access to sugar

2021-02-16
(Press-News.org) Cancer cells and immune cells share something in common: They both love sugar.

Sugar is an important nutrient. All cells use sugar as a vital source of energy and building blocks. For immune cells, gobbling up sugar is a good thing, since it means getting enough nutrients to grow and divide for stronger immune responses. But cancer cells use sugar for more nefarious ends.

So, what happens when tumor cells and immune cells battle for access to the same supply of sugar? That's the central question that Memorial Sloan Kettering researchers Taha Merghoub, Jedd Wolchok, and Roberta Zappasodi explore in a new study published February 15 in the journal Nature.

Using mouse models and data from human patients, the researchers found a direct relationship between the amount of sugar -- specifically glucose -- that a tumor consumes and the effectiveness of immunotherapy: The more sugar the tumor consumed, the less effective the immunotherapy.

The findings suggest that blocking cancer cells' use of sugar could tip the scales in favor of immune cells, especially when they are activated by immunotherapy drugs.

"If we reduce a tumor's use of glucose, then we free up more of it for immune cells to use, which benefits the immune response," says Dr. Merghoub, who co-led the research effort.

"What we think we've identified is a new means to improve checkpoint blockade immunotherapy," adds Dr. Wolchok. Immune checkpoint inhibitors release the brakes on immune cells and can provide lasting benefits for people with cancer, but they do not work for everyone. The new research may provide a way to boost their effectiveness.

Dr. Wolchok, Chief of the Immuno-Oncology Service in the Human Oncology and Pathogenesis Program at MSK, also directs the Parker Institute for Cancer Immunotherapy at MSK and co-directs the Ludwig Center for Cancer Immunotherapy at MSK.

Vying for Resources

To examine the relationship between tumor cells' use of glucose and response to immunotherapy, the researchers turned to a mouse model of breast cancer that is highly glycolytic -- meaning it uses a lot of sugar to grow. In the first set of tumors, the researchers genetically knocked down a key enzyme cells require to rapidly consume glucose in a process called glycolysis. In the second set, the enzyme was left alone. Each set of tumors was grown in mice and then the mice were treated with checkpoint inhibitors targeting CTLA-4 before having surgery to remove the tumor. The results: The mice whose tumors consumed less sugar survived longer and had a far lower rate of metastasis (when the cancer spreads) than the mice with tumors that used more glucose. This indicated an improved response to immunotherapy in mice whose tumors consumed less glucose.

Moreover, the improved immune response exhibited memory. When researchers re-implanted tumors in the mice exposed to the less-glycolytic tumors, tumor growth remained suppressed. By contrast, mice exposed to the more-glycolytic tumors were not able to control the growth of re-implanted tumors.

The team also looked at human data. When they measured glucose use by tumors and compared that to the number of immune cells present in a tumor, they found that the two measures were inversely correlated: The higher the glucose use by tumors, the fewer immune cells present.

Releasing Multiple Brakes

When it comes to immune checkpoint blockade, two types of T cells are crucially important -- effector T cells and regulatory T cells (Tregs). Effector T cells are the ones that actually attack cancer cells and kill them, whereas Tregs serve as a kind of brake on the effector T cells.

It turns out that glucose affects these two T cell types differently. More available glucose boosts the effector T cells' killing ability. With Tregs, more glucose means they lose their ability to apply the brakes. That means that freeing up glucose for use by immune cells is doubly beneficial at giving a boost to immunotherapy drugs.

"It was surprising and exciting to see that CTLA-4 blockade induces Tregs to use glucose and that this in turn reduces the suppression activity of these cells," says Dr. Zappasodi, a former Parker Institute Bridge Scholar in the Merghoub-Wolchok lab and now a faculty member at Weill Cornell Medicine.

"The implication is that for tumors that are highly glycolytic and don't respond to immune checkpoint blockade, one way of overcoming this resistance is to target tumor glycolysis with drugs," Dr. Merghoub adds.

The feasibility of using sugar to boost immune responses depends on being able to preferentially limit glucose use by tumors -- and that's where it gets tricky. Existing drugs that block sugar use by cancer cells will also block sugar use by immune cells, which would defeat the purpose. What is needed are drugs that can prevent tumor cells from using glucose while allowing immune cells to use it freely. The team has a few leads and is exploring them now.

INFORMATION:

This research was funded in part through the NIH/NCI (grants R01 CA215136-01A, R50 CA221810, T32CA082084, F31AI149971, DP2AI136598, R21AI135367, and Cancer Center Support Grant P30 CA00874)8, Swim Across America, Ludwig Institute for Cancer Research, Parker Institute for Cancer Immunotherapy, the Breast Cancer Research Foundation, SNSF project grants (31003A_182470), and European Research Council Staring Grant (802773-MitoGuide). Dr. Zappasodi is an inventor on patent applications related to work on GITR, PD-1, and CTLA-4, and is a consultant for Leap Therapeutics and iTEOS Belgium SA. Dr. Merghoub is a cofounder and holds an equity in IMVAQ Therapeutics and is a consultant of Immunos Therapeutics, Pfizer, and Immunogenesis. Dr. Merghoub has research support from Bristol Myers Squibb; Surface Oncology; Kyn Therapeutics; Infinity Pharmaceuticals, Inc.; Peregrine Pharmaceuticals, Inc.; Adaptive Biotechnologies; Leap Therapeutics, Inc.; and Aprea. He has patents on applications related to work on oncolytic viral therapy, alpha virus-based vaccine, neoantigen modeling, CD40, GITR, OX40, PD-1, and CTLA-4. Dr. Wolchok is a consultant for Adaptive Biotech; Amgen; Apricity; Ascentage Pharma; Astellas; AstraZeneca; Bayer; Beigene; Boehringer Ingelheim; Bristol Myers Squibb; Celgene; Chugai; Eli Lilly; Elucida; F Star; Georgiamune; Imvaq; Kyowa Hakko Kirin; Linneaus; Merck; Neon Therapeutics; Polynoma; Psioxus; Recepta; Takara Bio; Trieza; Truvax; Sellas; Serametrix; Surface Oncology; Syndax; Syntalogic; and Werewolf Therapeutics. He reports grants from Bristol Myers Squibb and Sephora and has equity in Tizona Pharmaceuticals; Adaptive Biotechnologies; Imvaq; Beigene; Linneaus; Apricity; Arsenal IO; and Georgiamune. Dr. Wolchok is an inventor on patent applications related to work on DNA vaccines in companion animals with cancer, assays for suppressive myeloid cells in blood, oncolytic viral therapy, alphavirus-based vaccines, neoantigen modeling, CD40, GITR, OX40, PD-1, and CTLA-4.



ELSE PRESS RELEASES FROM THIS DATE:

Regional variation in the impacts of the COVID-19 pandemic on data collection

Regional variation in the impacts of the COVID-19 pandemic on data collection
2021-02-16
Ithaca, NY--The COVID-19 pandemic has changed life as we know it all around the world. It's changed human behavior, and that has major consequences for data-gathering citizen-science projects such as eBird, run by the Cornell Lab of Ornithology. This worldwide database now contains more than a billion observations and is a mainstay of many scientific studies of bird populations. Newly published research in the journal Biological Conservation finds that when human behaviors change, so do the data. "We examined eBird data submitted during April 2020 and compared them to data from April of prior years," explains lead ...

Unlocking the mystery behind skeletal aging

2021-02-16
Researchers from the UCLA School of Dentistry have identified the role a critical enzyme plays in skeletal aging and bone loss, putting them one step closer to understanding the complex biological mechanisms that lead to osteoporosis, the bone disease that afflicts some 200 million people worldwide. The findings from their study in mice, END ...

Exercise now proven to have mental health benefits for prostate cancer

Exercise now proven to have mental health benefits for prostate cancer
2021-02-16
New Edith Cowan University (ECU) research has found that exercise not only has physical benefits for men with prostate cancer, it also helps reduce symptoms of depression and anxiety. Up to one in four men experience anxiety either before or after prostate cancer treatment and up to one in five report depression, although few men access the support they need. The study, published in the Nature journal Prostate Cancer and Prostatic Diseases, is the first randomised controlled trial to examine the long-term effects of different exercise on psychological distress in men with prostate cancer undergoing androgen deprivation therapy (ADT). Researchers randomly selected 135 prostate cancer patients aged ...

FRESH 3D-printing platform paves way for tissues, organs

FRESH 3D-printing platform paves way for tissues, organs
2021-02-16
WASHINGTON, February 16, 2021 -- Research into 3D bioprinting has grown rapidly in recent years as scientists seek to re-create the structure and function of complex biological systems from human tissues to entire organs. The most popular 3D printing approach uses a solution of biological material or bioink that is loaded into a syringe pump extruder and deposited in a layer-by-layer fashion to build the 3D object. Gravity, however, can distort the soft and liquid bioinks used in this method. In APL Bioengineering, by AIP Publishing, researchers from Carnegie Mellon University provide perspective on the Freefrom Reversible Embedding of Suspended Hydrogels ...

Association of maternal cardiovascular health during pregnancy with later health of offspring in adolescence

2021-02-16
What The Study Did: The observational study examined associations between maternal cardiovascular health during pregnancy (as measured by body mass index, blood pressure, total cholesterol level, glucose level and smoking) with the later cardiovascular health of their offspring at ages 10 to 14 years old (as measured by body mass index, blood pressure, total cholesterol level and glucose level). Authors: Amanda M. Perak, M.D., M.S., of the Northwestern University Feinberg School of Medicine in Chicago, is the corresponding author. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jama.2021.0247) Editor's Note: The article includes conflicts of interest and funding/support ...

Low-value health care drops only marginally despite effort to curb practices

2021-02-16
Spending on low-value health care among fee-for-service Medicare recipients dropped only marginally from 2014 to 2018, despite both a national campaign to better educate clinicians and increasing use of payment revisions that discourage wasteful care, according to a new RAND Corporation study. Three items accounted for two-thirds of the low-value care. Among these, prescribing opioids for acute back pain increased despite a growing national awareness of the harms caused by the drugs and the role of such prescribing in fueling the nation's opioid ...

Association of armed guards, severity of school shootings

2021-02-16
What The Study Did: Researchers examined the association between the presence of an armed guard on scene and the severity of shootings at schools kindergarten through high school. Authors: Jillian Peterson, Ph.D., of Hamline University in St. Paul, Minnesota, is the corresponding author. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2020.37394) Editor's Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support. INFORMATION: Media advisory: The full study is linked to this ...

Role of diet in risk of colorectal cancer

2021-02-16
What The Study Did: Researchers examined the strength of the evidence from published meta-analyses of observational studies that looked at the association between diet and the risk of colorectal cancer. Authors: Nathorn Chaiyakunapruk, Pharm.D., Ph.D., of the University of Utah in Salt Lake City, is the corresponding author. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/  (doi:10.1001/jamanetworkopen.2020.37341) Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support. INFORMATION: Media ...

Hydrogel promotes wound healing better than traditional bandages, gauzes

Hydrogel promotes wound healing better than traditional bandages, gauzes
2021-02-16
WASHINGTON, February 16, 2021 -- The widespread use of high-speed and high-energy weapons in modern warfare has led to an increasing incidence of explosive injuries. For such wounds as well as those incurred in disasters and accidents, severe hemorrhage is the leading cause of death. In APL Bioengineering, by AIP Publishing, researchers from the Southern University of Science and Technology in China examine the advances in hydrogel dressings in recent years, which are good at promoting wound healing and can better meet the demands of different situations. "With the rapid developments of material science, there are numerous highly ...

Mother's heart health in pregnancy impacts child's heart health in adolescence

2021-02-16
CHICAGO --- A mother's heart health while she is pregnant may have a significant impact on her child's cardiovascular health in early adolescence (ages 10 to 14), according to a new study from Northwestern Medicine and the Ann & Robert H. Lurie Children's Hospital of Chicago. The study will be published Feb. 16 in the Journal of the American Medical Association (JAMA). It is the first study to examine the implications of a mother's cardiovascular health during pregnancy for offspring health in the longer term. The findings are troubling, as they build upon previous Northwestern Medicine and Lurie Children's Hospital research that found ...

LAST 30 PRESS RELEASES:

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

Mission accomplished for the “T2T” Hong Kong Bauhinia Genome Project

[Press-News.org] To improve immunotherapy, researchers look to shift immune cells' access to sugar